Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for PRPO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 0.66M
March 31, 2026 0.064M
December 31, 2025 0.366M
September 30, 2025 0.01M
June 30, 2025 0.353M
March 31, 2025 -0.044M
December 31, 2024 0.565M
September 30, 2024 0.041M
June 30, 2024 0.50M
March 31, 2024 -0.667M
December 31, 2023 0.114M
September 30, 2023 -0.896M
June 30, 2023 -1.202M
March 31, 2023 -1.575M
December 31, 2022 -1.50M
September 30, 2022 -2.241M
June 30, 2022 -1.646M
March 31, 2022 -2.334M
December 31, 2021 -1.40M
September 30, 2021 -2.129M
June 30, 2021 -1.759M
March 31, 2021 -1.289M
December 31, 2020 -1.451M
September 30, 2020 -2.421M
June 30, 2020 -1.973M
Date Value
March 31, 2020 -1.589M
December 31, 2019 -2.14M
September 30, 2019 -2.114M
June 30, 2019 -3.008M
March 31, 2019 -1.879M
December 31, 2018 -1.953M
September 30, 2018 -1.19M
June 30, 2018 -2.466M
March 31, 2018 -1.145M
December 31, 2017 -2.209M
September 30, 2017 -3.584M
June 30, 2017 -0.571M
March 31, 2017 -0.326M
December 31, 2016 -0.317M
September 30, 2016 -0.252M
June 30, 2016 1.534M
March 31, 2016 -1.924M
December 31, 2015 -2.95M
September 30, 2015 -3.416M
June 30, 2015 -2.499M
March 31, 2015 -3.513M
December 31, 2014 -2.493M
September 30, 2014 -3.952M
June 30, 2014 -3.391M
March 31, 2014 -3.866M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
NeoGenomics, Inc. 19.96M
Quest Diagnostics, Inc. 597.00M
Labcorp Holdings, Inc. 445.50M
OPKO Health, Inc. -43.50M
Psychemedics Corp. --